Volpe Stefania, Isaksson Lars Johannes, Zaffaroni Mattia, Pepa Matteo, Raimondi Sara, Botta Francesca, Lo Presti Giuliana, Vincini Maria Giulia, Rampinelli Cristiano, Cremonesi Marta, de Marinis Filippo, Spaggiari Lorenzo, Gandini Sara, Guckenberger Matthias, Orecchia Roberto, Jereczek-Fossa Barbara Alicja
Division of Radiation Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Transl Lung Cancer Res. 2022 Dec;11(12):2452-2463. doi: 10.21037/tlcr-22-248.
No evidence supports the choice of specific imaging filtering methodologies in radiomics. As the volume of the primary tumor is a well-recognized prognosticator, our purpose is to assess how filtering may impact the feature/volume dependency in computed tomography (CT) images of non-small cell lung cancer (NSCLC), and if such impact translates into differences in the performance of survival modeling. The role of lesion volume in model performances was also considered and discussed.
Four-hundred seventeen CT images NSCLC patients were retrieved from the NSCLC-Radiomics public repository. Pre-processing and features extraction were implemented using Pyradiomics v3.0.1. Features showing high correlation with volume across original and filtered images were excluded. Cox proportional hazards (PH) with least absolute shrinkage and selection operator (LASSO) regularization and CatBoost models were built with and without volume, and their concordance (C-) indices were compared using Wilcoxon signed-ranked test. The Mann Whitney U test was used to assess model performances after stratification into two groups based on low- and high-volume lesions.
Radiomic models significantly outperformed models built on only clinical variables and volume. However, the exclusion/inclusion of volume did not generally alter the performances of radiomic models. Overall, performances were not substantially affected by the choice of either imaging filter (overall C-index 0.539-0.590 for Cox PH and 0.589-0.612 for CatBoost). The separation of patients with high-volume lesions resulted in significantly better performances in 2/10 and 7/10 cases for Cox PH and CatBoost models, respectively. Both low- and high-volume models performed significantly better with the inclusion of radiomic features (P<0.0001), but the improvement was largest in the high-volume group (+10.2% against +8.7% improvement for CatBoost models and +10.0% against +5.4% in Cox PH models).
Radiomic features complement well-known prognostic factors such as volume, but their volume-dependency is high and should be managed with vigilance. The informative content of radiomic features may be diminished in small lesion volumes, which could limit the applicability of radiomics in early-stage NSCLC, where tumors tend to be small. Our results also suggest an advantage of CatBoost models over the Cox PH models.
在放射组学中,尚无证据支持特定成像滤波方法的选择。由于原发肿瘤体积是一个公认的预后指标,我们的目的是评估滤波如何影响非小细胞肺癌(NSCLC)计算机断层扫描(CT)图像中的特征/体积依赖性,以及这种影响是否会转化为生存模型性能的差异。还考虑并讨论了病变体积在模型性能中的作用。
从NSCLC - Radiomics公共数据库中检索了417例NSCLC患者的CT图像。使用Pyradiomics v3.0.1进行预处理和特征提取。排除在原始图像和滤波图像中与体积高度相关的特征。构建了包含和不包含体积因素的具有最小绝对收缩和选择算子(LASSO)正则化的Cox比例风险(PH)模型和CatBoost模型,并使用Wilcoxon符号秩检验比较它们的一致性(C -)指数。基于低体积和高体积病变将患者分层后,使用Mann Whitney U检验评估模型性能。
放射组学模型显著优于仅基于临床变量和体积构建的模型。然而,体积因素的排除/纳入通常不会改变放射组学模型的性能。总体而言,性能不受成像滤波器选择的实质性影响(Cox PH模型的总体C指数为0.539 - 0.590,CatBoost模型为0.589 - 0.612)。对于高体积病变患者的分层,分别在Cox PH模型和CatBoost模型的2/10和7/10病例中导致显著更好的性能。包含放射组学特征时,低体积和高体积模型的表现均显著更好(P<0.0001),但在高体积组中改善最大(CatBoost模型提高了10.2%,而Cox PH模型提高了8.7%;Cox PH模型提高了10.0%,而CatBoost模型提高了5.4%)。
放射组学特征很好地补充了诸如体积等众所周知的预后因素,但其体积依赖性很高,应谨慎处理。在小病变体积中,放射组学特征的信息含量可能会减少,这可能会限制放射组学在早期NSCLC(肿瘤往往较小)中的适用性。我们的结果还表明CatBoost模型优于Cox PH模型。